Skip to main content
博迅生物 logo

博迅生物 — Investor Relations & Filings

Ticker · 920504 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 301 across all filing types
Latest filing 2024-05-13 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920504

About 博迅生物

http://www.boxun.com.cn/

Boxun Medical Biological Instrument Corp. specializes in the development and manufacture of laboratory equipment and medical instruments. The company's core product line includes high-pressure steam sterilizers, constant temperature incubators, CO2 incubators, drying ovens, and environmental test chambers. These instruments are designed for applications in life sciences, healthcare, pharmaceutical research, and environmental monitoring. Boxun focuses on delivering precise thermal control and reliable sterilization solutions, ensuring compliance with international quality standards. Its equipment is utilized in scientific research, clinical diagnostics, and industrial quality control to maintain sterile environments and stable experimental conditions. The company emphasizes technical innovation and product durability to support the requirements of modern laboratory facilities.

Recent filings

Filing Released Lang Actions
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of an invention patent certificate. It details the patent number, application date, and the technical field of the invention. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no management changes, no voting results, no capital changes, or any other financial or governance report. The document is a regulatory announcement about intellectual property rights, which does not fit into any of the specific financial or governance report categories. Therefore, it falls under the fallback category of Regulatory Filings (RNS). The document length is short and it is not an announcement of a report publication but a standalone announcement about a patent. Hence, the classification is RNS with high confidence.
2024-05-13 Chinese
第三届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting date, attendance, and the approval of a proposal regarding the company's 2024 first quarter report. However, the actual first quarter report is referenced as being disclosed separately on the Beijing Stock Exchange information disclosure platform (announcement number 2024-044). The document itself does not contain financial data or the report content but is an announcement of the meeting resolution approving the report. Given the short length (792 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than the actual Interim/Quarterly Report (IR).
2024-04-25 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2024 年第一季度报告" which translates to "2024 First Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the period ending March 31, 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the quarter. It is not an announcement or a brief summary but a full financial report for a period shorter than a fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-25 Chinese
第三届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 17th meeting of the 3rd Board of Directors of Shanghai Boxun Medical Biological Instruments Co., Ltd. It includes details about the meeting date, attendance, and voting results on the agenda items. The key agenda item mentioned is the approval of the company's 2024 first quarter report, but the actual report is referenced as being disclosed separately on the Beijing Stock Exchange information disclosure platform (announcement number 2024-044). The document itself does not contain the financial data or the report but is an announcement of the board meeting resolutions. This fits the category of Board/Management Information (MANG) because it announces board meeting decisions and management resolutions rather than the report itself or voting results at a shareholder meeting.
2024-04-25 Chinese
第三届监事会第十三次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolution from the 13th meeting of the third Supervisory Board of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the meeting date, attendance, agenda, and voting results specifically about the election of the Supervisory Board chairman. There is no financial data, no mention of annual or interim reports, no audit information, and no regulatory filings or certifications. The content focuses on board-level management changes, specifically the election of a supervisory board chairman. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of a board decision.
2024-04-21 Chinese
2023年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2023 annual equity distribution (dividend) plan of Shanghai Boxun Medical Biological Instruments Co., Ltd. It details the dividend amount, payment dates, tax information, and shareholder eligibility. It references the shareholders' meeting approval but does not contain full financial statements or detailed financial performance data. The document is short (1260 characters) and focuses on dividend distribution details rather than presenting a full annual report or financial results. Therefore, it fits the category of a Notice of Dividend Amount (DIV).
2024-04-21 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.